# Voiding Efficiency, a Predictor of Clean Intermittent Catheterization (CIC)

> **NCT03043287** · — · COMPLETED · sponsor: **Allergan** · enrollment: 420 (actual)

## Conditions studied

- Urinary Bladder, Overactive

## Interventions

- **BIOLOGICAL:** onabotulinumtoxinA

## Key facts

- **NCT ID:** NCT03043287
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-12
- **Primary completion:** 2019-09-09
- **Final completion:** 2019-09-30
- **Target enrollment:** 420 (ACTUAL)
- **Last updated:** 2020-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03043287

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03043287, "Voiding Efficiency, a Predictor of Clean Intermittent Catheterization (CIC)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03043287. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*